PL3164393T3 - Pochodne flawaglin - Google Patents
Pochodne flawaglinInfo
- Publication number
- PL3164393T3 PL3164393T3 PL15733767T PL15733767T PL3164393T3 PL 3164393 T3 PL3164393 T3 PL 3164393T3 PL 15733767 T PL15733767 T PL 15733767T PL 15733767 T PL15733767 T PL 15733767T PL 3164393 T3 PL3164393 T3 PL 3164393T3
- Authority
- PL
- Poland
- Prior art keywords
- flavagline derivatives
- flavagline
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1456474A FR3023290B1 (fr) | 2014-07-04 | 2014-07-04 | Derives de flavaglines |
| PCT/EP2015/065294 WO2016001441A1 (fr) | 2014-07-04 | 2015-07-06 | Dérivés de flavaglines |
| EP15733767.6A EP3164393B1 (fr) | 2014-07-04 | 2015-07-06 | Dérivés de flavaglines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3164393T3 true PL3164393T3 (pl) | 2019-03-29 |
Family
ID=52016681
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15733767T PL3164393T3 (pl) | 2014-07-04 | 2015-07-06 | Pochodne flawaglin |
| PL18187037.9T PL3418273T3 (pl) | 2014-07-04 | 2015-07-06 | Pochodne flawaglin |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL18187037.9T PL3418273T3 (pl) | 2014-07-04 | 2015-07-06 | Pochodne flawaglin |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US10047064B2 (enExample) |
| EP (3) | EP3418273B1 (enExample) |
| JP (4) | JP6637954B2 (enExample) |
| DK (2) | DK3164393T3 (enExample) |
| ES (2) | ES2700156T3 (enExample) |
| FR (1) | FR3023290B1 (enExample) |
| PL (2) | PL3164393T3 (enExample) |
| TR (1) | TR201819805T4 (enExample) |
| WO (1) | WO2016001441A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3023290B1 (fr) * | 2014-07-04 | 2016-08-19 | Pf Medicament | Derives de flavaglines |
| JP7105691B2 (ja) | 2015-11-25 | 2022-07-25 | イーフェクター セラピューティクス， インコーポレイテッド | Ｅｉｆ４ａ－阻害化合物およびそれに関連する方法 |
| MX388833B (es) * | 2017-06-19 | 2025-03-12 | Futurechem Co Ltd | Compuesto marcado con 18f para diagnostico de cancer de prostata y uso de este |
| EP3755693B1 (en) * | 2018-02-19 | 2024-06-12 | Memorial Sloan-Kettering Cancer Center | Agents and methods for treating dysproliferative diseases |
| WO2019200017A1 (en) | 2018-04-10 | 2019-10-17 | Cellectar Biosciences, Inc. | Phospholipid-flavagline conjugates and methods of using the same for targeted cancer therapy |
| EP3863625A4 (en) * | 2018-10-09 | 2022-06-29 | The Research Institute at Nationwide Children's Hospital | Anticancer rocaglamide derivatives |
| WO2020086562A1 (en) * | 2018-10-22 | 2020-04-30 | Trustees Of Boston University | Compositions and methods for inhibiting viral infection |
| MX2022004341A (es) | 2019-10-10 | 2022-08-10 | Cellectar Biosciences Inc | Conjugados de fosfolípido-flavaglina y métodos para usar los mismos para la terapia dirigida al cáncer. |
| WO2025104293A1 (en) * | 2023-11-17 | 2025-05-22 | Gustave Roussy Transfert | Inhibitors of eif4a and uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPQ866500A0 (en) * | 2000-07-05 | 2000-08-03 | Exgenix Operations Pty Ltd | Therapeutic compounds and methods |
| DE102004024504A1 (de) | 2004-05-18 | 2006-02-16 | Bayer Healthcare Ag | Neue Cylopenta[b]benzofuran-Derivate und ihre Verwendung |
| WO2007139749A2 (en) * | 2006-05-22 | 2007-12-06 | Trustees Of Boston University | Asymmetric synthesis of rocaglamides via enantioselective photocycloaddition mediated by chiral bronsted acids |
| EP2189453A1 (en) * | 2008-11-25 | 2010-05-26 | Université Louis Pasteur | Rocaglaol derivatives as cardioprotectant agents |
| JP2012510964A (ja) * | 2008-12-05 | 2012-05-17 | インターメッド・ディスカバリー・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | Ｈｉｆ−１蛋白蓄積の阻害剤 |
| FR3023290B1 (fr) * | 2014-07-04 | 2016-08-19 | Pf Medicament | Derives de flavaglines |
-
2014
- 2014-07-04 FR FR1456474A patent/FR3023290B1/fr active Active
-
2015
- 2015-07-06 EP EP18187037.9A patent/EP3418273B1/fr active Active
- 2015-07-06 PL PL15733767T patent/PL3164393T3/pl unknown
- 2015-07-06 US US15/323,650 patent/US10047064B2/en active Active
- 2015-07-06 DK DK15733767.6T patent/DK3164393T3/en active
- 2015-07-06 JP JP2017500083A patent/JP6637954B2/ja active Active
- 2015-07-06 EP EP21213303.7A patent/EP3998257A1/fr active Pending
- 2015-07-06 PL PL18187037.9T patent/PL3418273T3/pl unknown
- 2015-07-06 ES ES15733767T patent/ES2700156T3/es active Active
- 2015-07-06 WO PCT/EP2015/065294 patent/WO2016001441A1/fr not_active Ceased
- 2015-07-06 TR TR2018/19805T patent/TR201819805T4/tr unknown
- 2015-07-06 ES ES18187037T patent/ES2908225T3/es active Active
- 2015-07-06 EP EP15733767.6A patent/EP3164393B1/fr active Active
- 2015-07-06 DK DK18187037.9T patent/DK3418273T3/da active
-
2017
- 2017-12-01 US US15/829,630 patent/US10519125B2/en active Active
-
2019
- 2019-12-20 JP JP2019230768A patent/JP6951406B2/ja active Active
-
2021
- 2021-09-22 JP JP2021154798A patent/JP7340574B2/ja active Active
-
2023
- 2023-08-25 JP JP2023137552A patent/JP2023159393A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3998257A1 (fr) | 2022-05-18 |
| US20170137400A1 (en) | 2017-05-18 |
| JP6637954B2 (ja) | 2020-01-29 |
| JP2022000455A (ja) | 2022-01-04 |
| EP3418273A1 (fr) | 2018-12-26 |
| DK3418273T3 (da) | 2022-03-21 |
| US10519125B2 (en) | 2019-12-31 |
| ES2700156T3 (es) | 2019-02-14 |
| US10047064B2 (en) | 2018-08-14 |
| JP7340574B2 (ja) | 2023-09-07 |
| WO2016001441A1 (fr) | 2016-01-07 |
| JP2017519796A (ja) | 2017-07-20 |
| DK3164393T3 (en) | 2019-01-21 |
| EP3164393B1 (fr) | 2018-09-19 |
| JP2020063289A (ja) | 2020-04-23 |
| JP2023159393A (ja) | 2023-10-31 |
| ES2908225T3 (es) | 2022-04-28 |
| TR201819805T4 (tr) | 2019-01-21 |
| FR3023290B1 (fr) | 2016-08-19 |
| FR3023290A1 (fr) | 2016-01-08 |
| JP6951406B2 (ja) | 2021-10-20 |
| US20180086729A1 (en) | 2018-03-29 |
| EP3418273B1 (fr) | 2022-01-12 |
| PL3418273T3 (pl) | 2022-08-01 |
| EP3164393A1 (fr) | 2017-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL253381B (en) | History of h9–pyrrolo–dipyridine | |
| ZA201704602B (en) | Dihydroindolizinone derivative | |
| SG11201609205WA (en) | Heterocyclyl-butanamide derivatives | |
| PL3418273T3 (pl) | Pochodne flawaglin | |
| HUE050450T2 (hu) | Fluoralkil-fluorén-származékok | |
| IL248773A0 (en) | History of naphthyridinedione | |
| IL251005B (en) | Pyrido-oxazinone derivatives | |
| IL248629A0 (en) | Substances containing diheteroaryl conjugated to cycloalkyl and their uses | |
| SMT201900438T1 (it) | Nuovi derivati di cyp-eicosanoide | |
| IL248772A0 (en) | A consequence of cyclohexyl pyridine | |
| PL3119744T3 (pl) | Pochodne 2-cyjano-3-cyklopropylo-3-hydroksy-N-arylo-tioakryloamidu | |
| GB201403686D0 (en) | EasyGo | |
| AU5585P (en) | Lanutah Mandevilla sanderi | |
| AU5591P (en) | Lanmontana Mandevilla sanderi | |
| AU5288P (en) | FLOMANTOG Mandevilla sanderi | |
| AU358508S (en) | Bedhead | |
| AP00670S1 (en) | Legate | |
| AU2014072V (en) | Duemarre Mandevilla sanderi | |
| GB201401945D0 (en) | Everfloat | |
| GB201400530D0 (en) | Cryptovote | |
| GB201400458D0 (en) | CUT584 Stylemaker | |
| GB201400278D0 (en) | Roller-ready |